Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma

This project was undertaken to develop the first set of consensus statements regarding the management of pancreatic ductal adenocarcinoma (PDAC) in Hong Kong, with the goal of providing guidance to local clinicians. A multidisciplinary panel of experts discussed issues surrounding current PDAC manag...

Full description

Saved in:
Bibliographic Details
Published in:Hong Kong medical journal = Xianggang yi xue za zhi 2024-04, Vol.30 (2), p.147-162
Main Authors: Chan, S L, Chiang, C L, Chok, K S H, Lee, A S, Tang, R S Y, Lim, F M Y, Lee, K F, Tai, A Y P, Lee, S W M, Lo, R C L, Chan, A W H, Mok, F P T
Format: Article
Language:English
Subjects:
Abdomen
Cancer therapies
Medical imaging
Pancreatic cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This project was undertaken to develop the first set of consensus statements regarding the management of pancreatic ductal adenocarcinoma (PDAC) in Hong Kong, with the goal of providing guidance to local clinicians. A multidisciplinary panel of experts discussed issues surrounding current PDAC management and reviewed evidence gathered in the local context to propose treatment recommendations. The experts used the Delphi approach to finalise management recommendations. Consensus was defined as ≥80% acceptance among all expert panel members. Thirty-nine consensus statements were established. These statements cover all aspects of PDAC management, including diagnosis, resectability criteria, treatment modalities according to resectability, personalised management based on molecular profiling, palliative care, and supportive care. This project fulfils the need for guidance regarding PDAC management in Hong Kong. To assist clinicians with treatment decisions based on varying levels of evidence and clinical experience, treatment options are listed in several consensus statements.
ISSN:1024-2708
2226-8707
DOI:10.12809/hkmj2210476